- Home
- INTS vs EDRY Comparison
INTS vs EDRY Comparison
Compare INTS & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- EDRY
- Stock Information
- Founded
- INTS 2012
- EDRY 2018
- Country
- INTS United States
- EDRY Greece
- Employees
- INTS N/A
- EDRY 296
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- INTS Health Care
- EDRY Consumer Discretionary
- Exchange
- INTS Nasdaq
- EDRY Nasdaq
- Market Cap
- INTS 30.8M
- EDRY 24.6M
- IPO Year
- INTS 2023
- EDRY N/A
- Fundamental
- Price
- INTS $1.30
- EDRY $8.95
- Analyst Decision
- INTS Strong Buy
- EDRY
- Analyst Count
- INTS 3
- EDRY 0
- Target Price
- INTS $8.50
- EDRY N/A
- AVG Volume (30 Days)
- INTS 37.8K
- EDRY 4.2K
- Earning Date
- INTS 05-08-2025
- EDRY 05-20-2025
- Dividend Yield
- INTS N/A
- EDRY N/A
- EPS Growth
- INTS N/A
- EDRY N/A
- EPS
- INTS N/A
- EDRY N/A
- Revenue
- INTS N/A
- EDRY $61,083,227.00
- Revenue This Year
- INTS N/A
- EDRY N/A
- Revenue Next Year
- INTS N/A
- EDRY $42.57
- P/E Ratio
- INTS N/A
- EDRY N/A
- Revenue Growth
- INTS N/A
- EDRY 28.35
- 52 Week Low
- INTS $1.27
- EDRY $8.00
- 52 Week High
- INTS $5.28
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- INTS 22.77
- EDRY 42.50
- Support Level
- INTS $1.78
- EDRY $8.40
- Resistance Level
- INTS $1.94
- EDRY $9.50
- Average True Range (ATR)
- INTS 0.17
- EDRY 0.62
- MACD
- INTS -0.03
- EDRY -0.01
- Stochastic Oscillator
- INTS 4.10
- EDRY 40.86
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.